Hepatobiliary Surgery Hospital and Institute of Chinese People’s Liberation Army (PLA) General Hospital, Beijing 100853, China; Division of Cardiology, Department of Medicine, College of Medicine, University of Florida, Gainesville 32608, USA; Department of Microbiology, Chinese PLA General Hospital, Beijing 100853, China; Department of General Practice, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou 310016, China; Department of General Surgery, National Institute for Health Research (NIHR) Comprehensive Biomedical Campus, Addenbrookes Hospital, Cambridge CB2000, UK; Department of General Surgery, Zhejiang Provincial People’s Hospital, Hangzhou 310014, China
chenhao.dr@gmail.com, dongjh301@163.com
Abstract: Reperfusion is the key strategy in acute ST-segment elevation myocardial infarction (STEMI) care, and it is time-dependent. Shortening the time from symptom to reperfusion and choosing the optimal reperfusion strategy for STEMI patients are great challenges in practice. We need to improve upon the problems of low reperfusion rate, non-standardized treatment, and economic burden in STEMI care. This article briefly reviews the current status of reperfusion strategy in STEMI care, and also introduces what we will do to bridge the gap between the guidelines and implementation in the clinical setting through the upcoming China STEMI early reperfusion program.